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Detection of Cytolethal Distending Toxin Activity and cdt Genes in Actinobacillus
Actinomycetemcomitans Isolates From Geographically Diverse Populations
Abstract
A cytolethal distending toxin (CDT) found in Actinobacillus actinomycetemcomitans inhibits the
eukaryotic cell cycle, which may contribute to the pathogenic potential of the bacterium. The presence of
the cdtABC genes and CDT activity were examined in 40 clinical isolates of A. actinomycetemcomitans
from Brazil, Kenya, Japan and Sweden. Thirty-nine of 40 cell lysates caused distension of Chinese
hamster ovary cells. At least one of the cdt genes was detected in all strains examined. The three cdt
genes were detected, by PCR, in 34 DNA samples. DNA from one strain from Kenya did not yield
amplicons of the cdtA and cdtB genes and did not express toxic activity. Restriction analysis was
performed on every amplicon obtained. PCR-RFLP patterns revealed that the three cdt genes were
conserved. These data provided evidence that the cdt genes are found and expressed in the majority of
the A. actinomycetemcomitans isolates. Although a quantitative difference in cytotoxicity was observed,
indicating variation in expression of CDT among strains, no clear relationship between CDT activity and
periodontal status was found.
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Abstract
A cytolethal distending toxin (CDT) found in Actinobacillus actinomycetemcomitans inhibits the
eukaryotic cell cycle, which may contribute to the pathogenic potential of the bacterium. The presence
of the cdtABC genes and CDT activity were examined in 40 clinical isolates of A.
actinomycetemcomitans from Brazil, Kenya, Japan and Sweden. Thirty-nine of 40 cell lysates caused
distension of Chinese hamster ovary cells. At least one of the cdt genes was detected in all strains
examined. The three cdt genes were detected, by PCR, in 34 DNA samples. DNA from one strain
from Kenya did not yield amplicons of the cdtA and cdtB genes and did not express toxic activity.
Restriction analysis was performed on every amplicon obtained. PCR-RFLP patterns revealed that
the three cdt genes were conserved. These data provided evidence that the cdt genes are found and
expressed in the majority of the A. actinomycetemcomitans isolates. Although a quantitative
difference in cytotoxicity was observed, indicating variation in expression of CDT among strains,
no clear relationship between CDT activity and periodontal status was found.
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Actinobacillus actinomycetemcomitans is associated with the etiology of periodontal diseases,
mainly aggressive periodontitis, and with non-oral infections such as endocarditis, meningitis,
osteomyelitis, glomerulonephritis and arthritis (9,33,36).
The microorganism produces several virulence factors that are involved in the colonization of
the oral cavity, the destruction and inhibition of regeneration of the periodontal tissues, and
interference with host defense mechanisms (36). The species shows significant variability
using either phenotyping or genotyping methods. Genetic methods, such as restriction fragment
length polymorphism (RFLP) analysis and arbitrarily primed polymerase chain reaction (APPCR), have been successfully used to show that specific genetic variants of A.
actinomycetemcomitans are associated with localized juvenile periodontitis (3,13).
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An important consideration in establishing that certain strains of A. actinomycetemcomitans
are potentially more virulent than others has been the variable expression of specific virulence
determinants. The most thoroughly characterized virulence factor in A.
actinomycetemcomitans, the leukotoxin, is genetically comprised of a cluster of four genes that
gives this species the ability to kill human neutrophils and macrophages (22,36). Variation in
the transcriptional regulation of the leukotoxin genes divides all A. actinomycetemcomitans
into high and low leukotoxin-producing strains. High leukotoxin-producing strains have a
deletion in the promoter region of the operon that enhances transcription (5). Variants with the
leukotoxin promoter deletion have a high prevalence in young localized juvenile periodontitissusceptible children who convert from a healthy to a diseased periodontal state (7). However,
variants containing the deletion are scarce in patients from Northern European and
Scandinavian countries, but are prevalent among localized juvenile periodontitis patients of
African origin (17,18). The contribution of the leukotoxin to localized juvenile periodontitis
in populations where the highly leukotoxic clone is absent is uncertain. The presence of low
leukotoxin-producing A. actinomycetemcomitans strains in subjects with aggressive forms of
periodontal disease as well as in healthy carriers implies that genetic, environmental and
acquired factors and, of course, the presence of other periopathogens differentiate the host
response to the specific bacterial agent.
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Interactions between A. actinomycetemcomitans and eukaryotic cells, relative to cytolethal
distending toxin (CDT) expression, are an important consideration in periodontal diseases
(24,31,34). This toxin arrests the growth of most eukaryotic cells in the G2/M phase (23,28,
32). CDT is found in several bacterial genera including some Escherichia coli strains (1,19,
30), Shigella dysenteriae (20,26), Campylobacter jejuni (21,27,37), Haemophillus ducreyi
(10) and Helicobacter spp. (8). The prevalence of CDT-expressing clones can vary among
populations of the same bacterial species. CDT-positive strains vary from 41% of the samples
of Campylobacter spp. in Bangladeshi (21) to 3.1% of the isolates of E. coli from children with
diarrhea and only 0.93% of E. coli isolates from healthy children (1). The prevalence of cdt
genes in strains varies from very high in certain species, for example H. ducreyi (10), to very
low, for example in S. dysenteriae (26) and E. coli (2,25).
The CdtB protein isolated from C. jejuni and E. coli was shown to be a DNase I-like protein,
leading to chromatin fragmentation in susceptible eukaryotic cells (15,16,23). The toxin enters
the eukaryotic cell by an as yet unidentified mechanism, and binds to the nucleus. The cell
cycle is blocked in the G2/M phase, probably as a result of inhibition of the cdc2 cyclin B1
complex (14,28).
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The cdt operon was found in a variable region of the chromosome of A.
actinomycetemcomitans Y4 by RFLP analysis (13,24). There are strong indications that the
CDT locus in A. actinomycetemcomitans may be of heterologous origin (24). Sonic extracts
of members of selected genetic variants (RFLP groups) (13) cause the distension and eventual
death of Chinese hamster ovary cells. Deletions in one or more of the cdt genes are prevalent
in fresh clinical isolates of A. actinomycetemcomitans (24).
In order to obtain more information on the world-wide distribution of this putative virulence
factor in A. actinomycetemcomitans, we determined the presence of the cdtABC genes by PCR,
and measured CDT activity against Chinese hamster ovary cells in strains isolated from the
subgingival plaque of subjects with various periodontal conditions living in geographically
diverse areas.
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Bacterial strains
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Forty clinical isolates of A. actinomycetemcomitans were screened for CDT activity with
Chinese hamster ovary cells and for cdt genes by PCR. The samples from Sweden (n=7) were
isolated in the Department of Microbiology, School of Dentistry, University of Gothenburg,
Sweden. Samples from Japan (n=5) were isolated from inactive sites of patients with deep
pockets (12). Samples from Kenya (n=6) originated from patients without periodontal bone
loss or light periodontal disease (11). Strains of A. actinomycetemcomitans from Brazil (n=22)
were isolated from patients with various periodontal conditions (Table 1). Samples from
periodontally healthy individuals (n=5) were obtained, in a cross-sectional study, from
adolescents in the city of São Paulo, Brazil (6). The other Brazilian samples were isolated from
patients with aggressive periodontitis (localized juvenile periodontitis) (n=8) and chronic
periodontitis (n=9) attending the clinic of the School of Dentistry, University of São Paulo,
and University Camilo Castello Branco. Strains FDC Y4 (genotype associated with low
leukotoxin production) and JP2 and UP6 (genotype associated with high leukotoxin
production), originally isolated in the United States from localized juvenile periodontitis
patients, were used as controls. The bacteria were kept frozen at −80°C in 10% skim milk
(Difco, Sparks, MD).
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CDT activity assay
CDT activity was determined as described by Johnson & Lior (19) with the modifications
suggested by Scott & Kaper (30). Aliquots from the frozen stock of A.
actinomycetemcomitans were inoculated on TSYE agar (tryptic soy agar with 0.6% yeast
extract) and incubated for 48 h at 37°C, in 5% CO2. The colonies were scraped from the agar
surface, suspended in phosphate-buffered saline solution (pH 7.3) and washed twice in the
same solution, and the cells were lysed by sonication for 1 min (Branson Sonifier 450, Branson
Ultrasonics Co., Danbury, CT) in an ice bath. The resultant lysates were centrifuged at 10 000
g for 10 min at 4°C (Eppendorf 5402, Eppendorf AG, Hamburg, Germany), to remove
unbroken cells and cellular debris. The supernatant fluids were sterilized by filtration through
0.22-μm filters (Millipore, Bedford, MA). The protein concentrations of the cell lysates were
determined using the Micron BCA Assay Kit (Pierce, Rockford, OH), and the lysates were
kept frozen at −80°C until use.
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Chinese hamster ovary cells were grown in 250-ml flasks containing 25 ml of F12 Ham’s
medium supplemented with 5% bovine fetal calf serum (Cultilab, São Paulo, Brazil), for 48 h
at 37°C in 5% CO2. Aliquots of 120 μl were removed from the Chinese hamster ovary cell
suspensions (2×104cells/ml) and added to each well of 96-well plates (Corning, NY). Aliquots
of each bacterial lysate containing 2, 10 or 20μg of protein were diluted to 30μl in F12 Ham’s
medium, and added to Chinese hamster ovary cells in each well. The same medium was added
to the wells that had not received bacterial extracts as a negative control. Cell lysates of E.
coli DH5α(Life Technologies, Gaitherburg, MD) were also tested as a negative control. The
medium was removed every 24 h and 150μl of fresh sterile medium containing 1% bovine fetal
calf serum was added to each well. The plates were incubated for 4 days at 37°C in 5% CO2.
After incubation, the cells were fixed with 10% formaldehyde for 5 min, and stained with 0.2%
crystal violet (Merck, Darmstadt, Germany). CDT activity was considered to be negative when
no morphological changes were observed. CDT activity was considered to be positive when
the Chinese hamster ovary cells exhibited the characteristic distension, as in the case of cells
treated with lysates from strain FDC Y4, JP2 or UP6 (positive controls). CDT activity was
scored as: +, 1–20% distended cells/well;++, 21–70% distended cells and no confluent growth;
+++, 70–100% distended cells or lack of cells. All experiments were performed in triplicate.
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Amplification of cdt genes

NIH-PA Author Manuscript

DNA was isolated from A. actinomycetemcomitans strains cultured on TSYE agar in an
atmosphere containing 5% CO2. Isolation of chromosomal DNA was based on the protocol
described by Ausubel (4). Briefly, the bacteria were resuspended in 567μl of TRIS-EDTA (TE)
buffer (pH 7.3) and lysed by the addition of 30μl of 10% sodium dodecyl sulfate (SDS) (Merck,
Darmstadt, Germany) and 3μl proteinase K (20 mg/ml, Gibco, Grand Island, MD) followed
by incubation at 37°C for 1 h. After cell lysis, 100μl of 53 NaCl and 80μl of 10%
cetyltrimethylammonium bromide (CTAB) (Sigma Chemical Co., St. Louis, MO)/0.73 NaCl
were added and the mixture was incubated at 65°C for 10 min. After extraction with phenol
(Amresco, Solon, OH)/chloroform/isoamyl alcohol (Sigma) (25/24/1 v/v/v), DNA was
precipitated with cold ethanol. The pellet was washed with 70% ethanol (Amresco) and
resuspended in TE buffer (pH 7.3).
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To amplify DNA by PCR, primers homologous to each cdt gene were used (Table 2). Primers
were constructed based on the FDC Y4 sequence published in GenBank (accession number:
AF006830). ‘Ready-To-Go PCR Beads’ (Amersham Pharmacia Biotech, Piscataway, NJ)
were used according to the manufacturer’s instructions. Twenty-five ng of chromosomal DNA
and 50 pmol of each primer (1μl) were added to each reaction. Amplification was performed
for 30 cycles at 94°C for 1 min, 50°C for 1 min and 72°C for 1 min, in a thermocycler (Perkin
Elmer Amp Gene, Norwalk, CT). Negative controls containing sterile water instead of DNA,
and positive controls containing FDC Y4 chromosomal DNA as the template were included
with every experiment. Experiments in which no amplicon was obtained, for at least one of
the cdt genes, were repeated using primers cdt (A)-pcr1 and cdt (C)-pcr2 as described above.
The PCR products were subjected to electrophoresis in 1% agarose gels (Sigma), in Trisacetate-Edta (TAE) buffer at 70 V for 2 h. The amplicons were visualized with an ultraviolet
transilluminator (Gel Doc 1000, Bio-Rad, Hercules, CA).
RFLP analysis
Amplicons representing the cdtA, B or C gene, or the entire operon (cdtABC), were digested
with a restriction endonuclease in a volume of 30μl, according to the manufacturer’s
recommendations (Gibco). Restriction endonucleases (shown in Table 3) were selected on the
basis of unique cleavage sites in each of the genes. The frequencies of restriction endonuclease
cleavage sites were determined using the LASERGENE MAP DRAW 4.05 Program
(DNASTAR Inc., Madison, WI) and the FDC Y4 DNA sequence (GenBank accession number
AF006830). The digested amplicons were resolved by electrophoresis in 2% agarose gels, in
TAE buffer at 70 V, for 2 h. The DNA fragments were stained with ethidium bromide and
photographed.
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Results
CDT activity
CDT activity was evaluated by microscopic observation of Chinese hamster ovary cells 4 days
after exposure to A. actinomycetemcomitans cell lysates. Lysate from E. coli DH5αdid not alter
the morphology of the Chinese hamster ovary cells. Chinese hamster ovary cells treated with
lysates from A. actinomycetemcomitans strain FDC Y4, UP6 or JP2 (positive controls)
exhibited the characteristic alterations in shape caused by CDT.
The effects of increasing concentrations of total cell lysate from the various A.
actinomycetemcomitans isolates on the Chinese hamster ovary cells are shown in Table 4.
These results were reproducible in triplicate experiments. Toxin activity was scored on the
basis of the percentage of Chinese hamster ovary cells in the culture that exhibited a
morphological change relative to controls (Fig. 1). Lysate from 39 of 40 clinical isolates caused
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an aberration in Chinese hamster ovary cell morphology (97.5%). Only strain OMGS414, from
Kenya, did not affect Chinese hamster ovary cell shape and number, even when as much as
20μg protein/well was added. However, as shown in Table 4, the amount of distension differed
among lysates from the various isolates. Cell lysates from only 19 strains exhibited CDT
activity at similar or higher levels than that observed for strain FDC Y4. Strains JP2 and UP6
caused more pronounced alterations in cell shape and number than strain FDC Y4. Lysates
from only two isolates of A. actinomycetemcomitans, both from patients with aggressive
periodontitis (localized juvenile periodontitis), produced an effect on Chinese hamster ovary
cells of the same magnitude as that caused by strains JP2 and UP6.
Identification and analysis of cdt genes
PCR reactions using primers homologous to the cdtA, B and C genes were performed with
DNA from the 40 isolates of A. actinomycetemcomitans. The results are shown in Table 4.
Amplification of the cdt genes in strains Y4 and JP2 was obtained in every PCR experiment.
DNA from all strains produced a single amplicon, of the expected size, for at least one of the
three cdt genes. Figure 2 shows the amplicons for the cdtA, B and C genes for the Y4 strain.
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Negative results were obtained with DNA from 12 of the isolates. These DNA samples were
amplified again using primers cdt (A)-PCR 1 and cdt (C)-PCR 2 in an attempt to produce an
amplicon containing all three cdt gene sequences. DNA from six (A24, C54-2, G56-1, G56-4,
G103-2 and OMGS181) of the 12 previously negative strains yielded amplicons of the expected
size of 2065 bp (Fig. 3). The three cdt genes were amplified from 34 of 40 clinical isolates
examined. These same strains also expressed CDT activity. DNA from the remaining six
strains, two isolated from periodontally healthy patients (C61 and C74-2) from Brazil, two
from Kenyan patients (OMGS 414, adult gingivitis, and OMGS 449, adult periodontitis) and
two from Japanese patients (OMGS 1519 and OMGS 1520: deep pocket, inactive sites), did
not produce an amplicon for at least one of the cdt genes, nor exhibited the complete operon
(Table 4).
The PCR products obtained from each reaction were digested with restriction endonucleases
to produce RFLP patterns (Table 3). Amplicons from all tested strains yielded DNA fragments
of the expected sizes as compared to FDC Y4 (see Fig. 2). Amplicons representing the intact
operon (genes cdtABC), from those strains that did not yield PCR products for the individual
cdt genes, were also subjected to RFLP analysis (Fig. 4). No differences in restriction sites
were detected.

Discussion
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Although A. actinomycetemcomitans is linked to the etiology of localized juvenile
periodontitis, the bacterium is also found in subjects who are healthy or have other forms of
periodontal disease. Differences in the virulence potential of strains of A.
actinomycetemcomitans may explain why some subjects are carriers and why there is an
increased prevalence of A. actinomycetemcomitans-associated periodontitis in certain
populations. Cytolethal distending toxin genes have been detected in A.
actinomycetemcomitans and in other organisms, their prevalence varying according to the
bacterial species (8,10,19,21,26). In this study we examined isolates from geographically
diverse locations to evaluate the distribution of cytolethal distending toxin activity and the
presence of cdt genes among strains of A. actinomycetemcomitans.
Total cell lysates from 39 of 40 clinical isolates induced morphological changes in Chinese
hamster ovary cells associated with CDT. However, distending activity similar to or higher
than that expressed by FDC Y4 was found in only 21 of 42 strains tested, including strains
UP6 and JP2. This variation in CDT activity in A. actinomycetemcomitans has also been
Oral Microbiol Immunol. Author manuscript; available in PMC 2008 September 23.
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observed among isolates from the United States (24). In that study, lysates from four genetic
variants of A. actinomycetemcomitans had low levels of toxin activity. Lysates from 10 RFLP
variants lacked CDT activity.
Twelve of the isolates examined in this study lacked at least one of the cdt genes as determined
by PCR analysis. This was not surprising, as the cdt gene locus appears to reside in a highly
unstable region on the FDCY4 chromosome and naturally occurring mutants have been
reported (24). Six of these 12 strains exhibited amplicons when the whole cdtABC gene operon
was amplified using primers homologous to the 5′?end of cdtA and the 3′?end of cdtC. These
results indicated the presence of the genes, although there was probably an absence of
homology with the primers used. These data were reinforced by the fact that strains A24,
G103-2 and OMGS181 did not show amplicons for the cdtA or the cdtB genes alone but showed
amplicons for the entire operon (cdtABC), and had a toxic effect on Chinese hamster ovary
cells similar to that induced by strain FDC Y4 cell lysate.
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CDT activity was observed with cell lysates from five strains in which cdtA, cdtC or cdtABC
was not detected by PCR. However, it should be noted that the toxic effects caused by cell
lysates from these strains [two isolates from healthy subjects in Brazil (C61 and C74-2), one
from a patient in Kenya (OMGS 449) and two from patients in Japan (OMGS1519 and
OMGS1520)] were lower than that observed with lysate from strain FDC Y4. The change in
cell morphology occurred in less than 20% of the Chinese hamster ovary cells, even when up
to 20μg of protein was added per well (Table 4).
The absence of amplicons from these strains may be attributable to a deletion of the gene or
lack of homology with the primer. However, it is also possible that there is a partial gene
deletion without a corresponding loss of toxin activity. It has been reported that the product of
cdtC is essential for the cytotoxic effect of A. actinomycetemcomitans (31). Mayer et al. (24)
observed that anti-CdtC monoclonal antibodies inhibited CDT activity. However, this same
study showed that a gene insertion 24 nucleotides upstream from the 3′end of the cdtC gene
resulted in no loss of activity. These data indicate that the last eight amino acids do not play a
role in the function of cdtC. In the present study, primer cdt(C)-PCR 2 is located on the 3′side
of the restriction site PinAI, where the interposon was inserted in cdtC (24). These data suggest
that naturally occurring mutants carrying a partial deletion in cdtC may be able to maintain
toxic activity.
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Recent data have shown that cdtB is the main component of a putative holotoxin (15,16,23).
In the present study, strain OMGS1520 from Japan exhibited an amplicon containing only the
cdtB sequence. Yet, this strain expressed low CDT activity. The only strain in which cdtB was
not amplified, OMGS414 from Kenya, did not exhibit a cytolethal effect, supporting the
concept that cdtB is an absolute requirement for the expression of toxin activity.
RFLP analysis of the amplicons (PCR-RFLP) revealed that the restriction endonuclease sites
were conserved in genes cdtA, B and C in most of the clinical isolates and in strain JP2. These
data are in agreement with those of Shenker et al. (32) comparing the sequence of cdt genes
of a minimally leukotoxic strain, A. actinomycetemcomitans 652, with the sequences published
in GenBank for the minimally leukotoxic strains FDC Y4 and ATCC 29522, and for the highly
leukotoxic strain HK1651 isolated in Europe from a localized juvenile periodontitis patient of
African origin.
The present data indicate that cdt genes and CDT activity are commonly found in strains of A.
actinomycetemcomitans from diverse geographical locations. The cdt genes and CDT activity
were found in strains from patients with every periodontal condition, as the Brazilian isolates
represented strains from patients with chronic periodontitis and aggressive periodontitis and a
healthy periodontium. Although all strains induced morphological changes in Chinese hamster
Oral Microbiol Immunol. Author manuscript; available in PMC 2008 September 23.
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ovary cells, the activity or amount of toxin produced differed among strains. Strain FDC Y4
promoted distension of more than 20% of the Chinese hamster ovary cells (designated ++)
with the addition of 20μg of cell lysate protein per well (Table 4). However, 20 of 40 clinical
isolates were unable to initiate CDT effects in more than 20% of the cells, even when 20μg of
protein was added to cultures. Cell lysates from four of the five isolates from healthy subjects
from Brazil caused very little alteration in Chinese hamster ovary cells. In contrast, 13 strains,
including strains JP2 and UP6, exhibited a highly toxic effect even when doses of protein from
cell lysates were ≤10μg. The only two strains that showed the toxic effect on >70% of the
Chinese hamster ovary cells, an effect similar to that observed for strains JP2 and UP6, were
isolates from Brazilian patients with localized juvenile periodontitis. However, no clear
relationship between CDT activity and periodontal status was found.
Cytolethal distending toxin activity and cdt genes were frequently found in strains of A.
actinomycetemcomitans from diverse geographical locations and were not specific for certain
clones. However, quantitative differences in CDT production were observed among strains,
which could be reflected in the virulence of the bacterium.
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Fig. 1.

Appearance of Chinese hamster ovary cells after 4 days of exposure to cell lysates of A.
actinomycetemcomitans. (A) No bacterial lysate;(B) bacterial lysate from strain OMGS 2460
(2.0 μg of protein/well, 1–20% of distention, +);(C) bacterial lysate from strain G92-1 (10.0
μg of protein/well, 21–70% of distention, ++);(D) bacterial lysate from strain G92-1 (20.0 μg
of protein/well, 70–100% of distention, +++).

NIH-PA Author Manuscript
Oral Microbiol Immunol. Author manuscript; available in PMC 2008 September 23.

Fabris et al.

Page 11

NIH-PA Author Manuscript
NIH-PA Author Manuscript
Fig. 2.
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RFLP patterns of cdt genes from strain FDC Y4. M, molecular weight marker (50 bp DNA
ladder).
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Fig. 3.

PCR of total DNA from representative strains of A. actinomycetemcomitans. Primers cdt (A)PCR 1 and cdt (C)-PCR 2 were used. M, molecular weight marker (low range molecular I
DNA).
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Fig. 4.

Restriction endonuclease map of the cdt gene region of strain FDC Y4. Amplicons cdtA-PCR
(583 bp), cdtB-PCR (790 bp), cdtC-PCR (512 bp) and cdtABC-PCR (2065 bp) are designated
by the heavy lines.
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Table 1

Race, age and periodontal condition of 18 Brazilian patients from whom 22 A. actinomycetemcomitans samples were
isolated

NIH-PA Author Manuscript

Strain
C34-2
C51-2
C54-2
C61
C74-2
A24
A26
G10-2
G56-1
G56-4
G59-3
G81-3
G92-1
G101
G101-2
G103-1
G103-2
G104-1
G104-2
G105-2
G111-1

Age in years
12
12
12
12
12
–
19
–
18
18
43
46
22
20
20
39
39
28
28
30
21

Race

Periodontal condition

–
–
–
–
–
–
Caucasian
–
Negroid
Negroid
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Caucasian
Negroid
Negroid
Caucasian
Caucasian

Healthy
Healthy
Healthy
Healthy
Healthy
Aggressive periodontitis
Aggressive periodontitis
Chronic periodontitis
Aggressive periodontitis
Aggressive periodontitis
Chronic periodontitis
Chronic periodontitis
Aggressive periodontitis
Aggressive periodontitis
Aggressive periodontitis
Chronic periodontitis
Chronic periodontitis
Chronic periodontitis
Chronic periodontitis
Chronic periodontitis
Aggressive periodontitis
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Table 2

Primers used in amplification of each cdt gene from A. actinomycetemcomitans, designed based on the analysis of the
sequence of strain FDC Y4 (GenBank accession number AF006830)

NIH-PA Author Manuscript

Primer

Sequence

Analysis

Product (bp)

cdt (A)-PCR1
cdt (A)-PCR2
cdt (B)-PCR1
cdt (B)-PCR2
cdt (C)-PCR1
cdt (C)-PCR2
cdt (A)-PCR1
cdt (C)-PCR2

5′?GGTTTAGTGGCTTGT 3′
5′?CACGTAATGGTTCTGTT 3′
5′?GGTTTTCTGTACGATGT 3′
5′?GGATGTAATTTGTGAGCGT 3′
5′?GACTTTGACGAGTCATGCA 3′
5′?CCTGATTTCTCCCCA 3′
5′?GGTTTAGTGGCTTGT 3′
5′?CCTGATTTCTCCCCA 3′

cdtA

583

cdtB

790

cdtC

512

cdtABC

2065
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Table 3

Number and position of restriction sites in amplicons of cdt genes, based on the analysis of the sequence of strain FDC
Y4 (GenBank accession number AF006830)

NIH-PA Author Manuscript

PCR product

Restriction enzyme

Sites

Fragment (bp)

cdtA

FokI
HaeII
HindIII
EcoRII
HindIII
NspI
DraI
EcoRII
BclI

1
1
1
1
1
1
1
1
1

139 e 444
242 e 341
381 e 202
248 e 542
363 e 427
455 e 335
223 e 289
256 e 256
289 e 223

cdtB
cdtC
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Table 4

Toxic activity on Chinese hamster ovary cells of cell lysates from 40 clinical
isolates and three control strains of A. actinomycetemcomitans, and detection of
cdtABC genes by PCR

NIH-PA Author Manuscript

Strain

NIH-PA Author Manuscript
NIH-PA Author Manuscript

USA
FDC Y4
JP2
UP6
Brazil
A24
A26
C34-2
C51-2
C54-2
C61
C74-2
G10-2
G56-1
G56-4
G59-3
G81-3
G92-1
G101
G101-2
G103-1
G103-2
G104-1
G104-2
G105-2
G111-1
G121-3
Sweden
OMGS161
OMGS 181
OMGS 183
OMGS 194
OMGS 250
OMGS 252
OMGS 2460
Kenya
OMGS 414
OMGS 420
OMGS 443
OMGS 449
OMGS 722
OMGS 723
Japan
OMGS 1519
OMGS 1520
OMGS 1522
OMGS 1523
OMGS 1526

CDT activity based on total protein (μg/well)1
2

10

20

Amplicons2

+
+
+

+
++
++

++
+++
+++

cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC

+
+
+
+
+
+
+
+
+
+
+
+
++
++
+
+
+
−
++
+
+
+

+
+
+
+
+
+
+
++
+
+
+
+
++
++
+
+
+
+
+
+
++
++

++
++
++
+
+
+
+
++
+
+
+
+
+++
+++
++
+
++
++
+
+
++
++

cdtB, cdtC, cdtABC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtC, cdtABC
cdtA, cdtB
cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtC, cdtABC
cdtB, cdtC, cdtABC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtB, cdtABC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC

+
+
+
+
+
+
+

++
+
+
+
++
+
++

++
++
+
+
++
+
++

cdtA, cdtB, cdtC
cdtA, cdtC, cdtABC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC

−
+
+
+
+
+

−
+
+
+
++
++

−
++
+
+
++
++

cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC

+
+
+
+
+

+
+
+
++
+

+
+
+
++
+

cdtA, cdtB
cdtB
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC
cdtA, cdtB, cdtC

1

−, absence of activity;+, 1–20% distended cells;++, 21–70% distended cells with loss of the confluent growth;+++, 70–100% distended cells and/or
absent cells.
2

cdtA, amplicon using primers cdt(A)-PCR1 and cdt(A)-PCR2;cdtB, amplicon using primers cdt(B)-PCR1 and cdt(B)-PCR2;cdtC, amplicon using primers
cdt(C)-PCR1 and cdt(C)-PCR2;cdtABC, amplicons in samples that, even if some of the cdt genes were not detected separately, gave a positive result
during the amplification with the cdt (A)-PCR1 and cdt (C)-PCR2 primers.
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